McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider
13 December 2019 - 3:01AM
Business Wire
Pharmaceutical
distributor continues long-standing relationship with VA Healthcare
System
McKesson Corporation (NYSE: MCK) announced today that it has
been selected by the Department of Veterans Affairs (VA), which
runs the nation’s largest integrated healthcare system, to continue
as the prime pharmaceutical supplier for the agency. Under the new
agreement, which takes effect in Aug. 2020, McKesson will supply
all of the VA's medical centers and outpatient clinics, as well as
the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). The
initial two-year contract includes options for up to three,
two-year extensions.
“McKesson has had the privilege of supporting the VA as their
prime pharmaceutical supplier since 2004,” said Brian Tyler,
McKesson’s chief executive officer. “We are honored to once again
be selected for the important responsibility of serving those who
serve us and providing quality care for our veterans.”
As part of the contract award, McKesson will continue to supply
pharmaceuticals to more than 750 locations, including more than 270
medical centers, as well as the VA's seven CMOPs.
McKesson is the largest non-defense vendor serving the U.S.
Department of Veterans Affairs, Department of Defense, and other
government branches.
Cautionary Statements
Except for historical information, matters contained in this
press release may constitute “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 that involve
risks and uncertainties that could cause actual results to differ
materially from those in those statements. Forward-looking
statements may be identified by their use of terminology such as
“will” or their references to future events. The reader should not
place undue reliance on forward-looking statements, which speak
only as of the date they are first made. Except to the extent
required by law, the company undertakes no obligation to publicly
update forward-looking statements. It is not possible to identify
all risks and uncertainties that could cause actual results to
differ materially from those in forward-looking statements, but
they include funding risks related to government contracts and
programs, compliance risks under government procurement and other
regulations, and risk that the VA may not exercise its rights to
extend the term of the new agreement. We encourage investors to
read the important risk factors described in the Risk Factors
section of the Company’s Form 10-K and Form 10-Q reports filed with
the Securities and Exchange Commission.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply
chain management solutions, retail pharmacy, community oncology and
specialty care, and healthcare information technology. McKesson
partners with pharmaceutical manufacturers, providers, pharmacies,
governments and other organizations in healthcare to help provide
the right medicines, medical products and healthcare services to
the right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day
to innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named the “Most Admired Company” in the
healthcare wholesaler category by FORTUNE, a “Best Place to Work”
by the Human Rights Campaign Foundation, and a top
military-friendly company by Military Friendly. For more
information, visit www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191212005547/en/
General and Business Media: David Matthews 214-952-0833
David.Matthews@McKesson.com
Investors and Financial Media: Holly Weiss 972-969-9174
Holly.Weiss@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Apr 2024 to May 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From May 2023 to May 2024